These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17551909)

  • 1. Hepatitis C virus infection and rituximab therapy after renal transplantation.
    Fabrizi F; Martin P; Elli A; Montagnino G; Banfi G; Passerini P; Campise MR; Tarantino A; Ponticelli C
    Int J Artif Organs; 2007 May; 30(5):445-9. PubMed ID: 17551909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of rituximab to hepatitis C-positive, ABO-incompatible renal transplantation.
    Tsai MK; Yang CY; Wu MS; Lee PH
    Int J Artif Organs; 2009 May; 32(5):308-9. PubMed ID: 19569040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
    Berney T; Delis S; Kato T; Nishida S; Mittal NK; Madariaga J; Levi D; Nery JR; Cirocco RE; Gelman B; Ruiz P; Tzakis AG
    Transplantation; 2002 Oct; 74(7):1000-6. PubMed ID: 12394845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.
    Sansonno D; De Re V; Lauletta G; Tucci FA; Boiocchi M; Dammacco F
    Blood; 2003 May; 101(10):3818-26. PubMed ID: 12506023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
    Petrarca A; Rigacci L; Caini P; Colagrande S; Romagnoli P; Vizzutti F; Arena U; Giannini C; Monti M; Montalto P; Matucci-Cerinic M; Bosi A; Laffi G; Zignego AL
    Blood; 2010 Jul; 116(3):335-42. PubMed ID: 20308604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation.
    Zilz ND; Olson LJ; McGregor CG
    J Heart Lung Transplant; 2001 Jul; 20(7):770-2. PubMed ID: 11448808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.
    Garcia VD; Bonamigo-Filho JS; Neumann J; Fogliatto L; Gaiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Santos AF; Roithmann S
    Transplant Proc; 2002 Nov; 34(7):2993-5. PubMed ID: 12431680
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center.
    Jain AB; Marcos A; Pokharna R; Shapiro R; Fontes PA; Marsh W; Mohanka R; Fung JJ
    Transplantation; 2005 Dec; 80(12):1692-8. PubMed ID: 16378063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-related lymphoproliferative disorders: an overview.
    Zignego AL; Giannini C; Ferri C
    World J Gastroenterol; 2007 May; 13(17):2467-78. PubMed ID: 17552031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
    Garcia VD; Bonamigo Filho JL; Neumann J; Fogliatto L; Geiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Ferrera des Santos A; Roithmann S
    Transpl Int; 2003 Mar; 16(3):202-6. PubMed ID: 12664217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
    Cornejo A; Bohnenblust M; Harris C; Abrahamian GA
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.
    O'Dwyer ME; Launder T; Rabkin JM; Nichols CR
    Leuk Lymphoma; 2000 Oct; 39(3-4):411-9. PubMed ID: 11342323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review.
    Messahel B; Taj MM; Hobson R; Hadzic N; Ramsay A; Hann I; Pinkerton R
    Leuk Lymphoma; 2006 Dec; 47(12):2584-9. PubMed ID: 17169802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab.
    Foxton MR; Knight L; Knisely AS; Mufti GJ; O'Grady J; Muiesan P; Norris S
    Liver Transpl; 2005 Jul; 11(7):839-842. PubMed ID: 15973713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.